München (ots) - Mehr Angebote als je zuvor gibt es vom 20. bis einschließlich 27. November 2017 während ...
Biomit Inc. Continues Expansion in Europe Affiliate office opened in Germany; representation in Benelux and Great Britain
Basel, Switzerland (ots) - Biomit Inc., a strategic e-clinical research partner for the biopharmaceutical industry, continues to establish offices throughout Europe as it expands its integrated worldwide representation. Today marks the official opening of its office in Heidelberg, which will coordinate on-line, electronic clinical research trials in Germany. As well, Biomit is now represented in Benelux and Great Britain to expand its reach in providing innovative, internet-based clinical research trial management.
Heading the Heidelberg office is Peter X. Kunz, PhD, who brings to Biomit extensive experience in clinical research, including eleven years as Clinical Research Scientist managing product development and international clinical trials. His fields of expertise include medical imaging in radiology, cardiology and urology, as well as ultrasound contrast media. Strategically located within the Heidelberg Technologypark with more than 30 biotech and pharma companies nearby, this affiliate office will coordinate marketing activities and clinical trials in Germany.
In addition, Dieter Wetzel, MD PhD, will represent Biomit in Benelux and Great Britain, assuming responsibilities for business development and clinical trial coordination there. With long-term experience in scientific information and drug development - including scientific drug information for and communication with health care professionals and patients, drug in- and out-licensing, analysis of drug markets and competitors, as well as marketing strategies and communication concepts - Dr. Wetzel is expert in the management of clinical trials and drug registration. Focus therapeutic areas include neurology and oncology.
"The opening of our office in Germany, together with representation in Benelux and Great Britain, marks an important second milestone in achieving our long-term goal of setting up operations throughout Europe," said Urs Gasser, co-founder and CSO of Biomit, who has recently become a Member of the Board of the Swiss Association of Pharmaceutical Professionals (SwAPP). "Dieter Wetzel and Peter Kunz are tremendous additions to our growing expert team of clinical research professionals."
Founded in September 2000, Biomit is an innovative clinical research organization (CRO) that combines the latest electronic data capture (EDC) technology with high scientific expertise in project management to ensure professional service when conducting clinical trials and to accelerate the development and delivery of new pharmaceutical and biotechnological products.
With an Internet-based tool (TRI@ L-IT(r)) that provides an innovative, flexible and fast solution for the execution of e-clinical trials, Biomit offers substantial quality improvement and significant cost and time reduction in support of any and all aspects of phase I-IV clinical trials within Europe, in a variety of therapeutic areas. Locally established in Central Europe with headquarters in Basel, Switzerland, Biomit is one of the first European-based clinical research organizations to conduct e-clinical trials. SiberHegner, a leading international marketing and services group with a 136-year history, represents Biomit in the United States. Additional information about Biomit is available at http:// www.biomit.com.
ots Originaltext: Biomit Inc.
Dr. Zuzana Dobbie
St. Alban Anlage 44
Dr. Peter X. Kunz
Biomit Deutschland GmbH
Im Neuenheimer Feld 582
Benelux, Great Britain:
Dr. Dieter Wetzel
D-51427 Bergisch Gladbach
Phone / Fax +49/2204-25783
Dr. Brigitte Sarrazin
Biomit France SAS
Parc Tertiaire Innolin
8, rue du Golf
33700 Merignac, France
Biomit Inc. c/o SiberHegner North America
300 East Lombard Street, Suite 630
Baltimore, MD 21202, USA